ID Update: The US FDA has revoked the Emergency Use Authorization (EUA) for these monoclonal antibodies used for COVID-19: Bebtelovimab, Casirivimab + Imdevimab (REGEN-COV), Sotrovimab, and Tixagevimab + Cilgavimab (Evusheld). https://buff.ly/433fH0L #IDSky
Comments